Federal auditors are looking into whether the Orphan Drug Act still serves its intended purpose and whether drugmakers may be abusing its incentives to maximize profits.
The co-founder of a Massachusetts compounding pharmacy was acquitted Wednesday of causing the deaths of 25 people but convicted of other racketeering charges in a nationwide meningitis outbreak in 2012.
PBMs and tech startups are responding to underinsurance and the onslaught of high-deductible health plans by cutting out insurers in the quest to help patients lower their prescription drug costs.
Decrying corporate greed, NYC Mayor Bill de Blasio blamed the pharmaceutical industry for killing New Yorkers as opioid-related overdose deaths rise in the city.
The cost of cancer drugs is skyrocketing while providing marginal value to patients, a new paper argues. How much longer can this go on?
Everett, a city in Washington, is suing Purdue Pharma, maker of the opioid pain medication OxyContin, in an unusual case that alleges the drugmaker knowingly allowed pills to be funneled into the black market and the city of about 108,000. Everett alleges the drugmaker did nothing to stop it and...
Case Western Reserve University School of Medicine and the Cleveland VA have teamed up to study and tackle antibiotic resistance through the establishment of a new center.
Many actors are known for their signature roles. For Ilana Becker, that role is of a dysfunctional digestive system.
The ongoing fight to establish a program to track opioid prescribing in Missouri has once again raised discussion on whether the country would be best served by a national monitoring system.
Drug distributors have come under fire as federal and state officials use the court system to fight the opioid crisis, and now county officials in West Virginia are following suit.
Will physicians choose one manufacturer's generic epinephrine auto-injector over another? Is it possible for them to do so?
Patients are flocking to alternatives to Mylan's EpiPen in the wake of the public relations disaster around the device's price, according to new data.